- Report
- August 2025
- 196 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- February 2025
- 200 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- March 2025
- 585 Pages
Global
From €6109EUR$6,995USD£5,307GBP
- Report
- March 2025
- 120 Pages
Global
From €4279EUR$4,900USD£3,717GBP
- Report
- May 2025
- 136 Pages
Global
From €2619EUR$2,999USD£2,275GBP
- Report
- August 2025
- 186 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 188 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 180 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- January 2025
- 200 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- October 2024
- 181 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- September 2025
- 376 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- September 2025
- 274 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- September 2025
- 372 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- March 2025
- 150 Pages
Global
From €3362EUR$3,850USD£2,921GBP
€4236EUR$4,850USD£3,680GBP
- Report
- November 2022
- 295 Pages
Global
From €4323EUR$4,950USD£3,755GBP
- Report
- March 2019
- 255 Pages
Global
From €2161EUR$2,475USD£1,878GBP
- Report
- January 2024
- 92 Pages
Europe
From €2576EUR$2,950USD£2,238GBP
- Report
- August 2024
- 128 Pages
Europe
From €3493EUR$4,000USD£3,035GBP
- Report
- May 2024
- 182 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- February 2024
- 120 Pages
Global
From €4148EUR$4,750USD£3,604GBP

The Cancer Profiling market within the Diagnostics industry is focused on the development of tests that can detect the presence of cancer in a patient. These tests are used to identify the type of cancer, its stage, and the best treatment options. Cancer profiling tests are used to detect genetic mutations, which can help doctors determine the best course of treatment for a patient. These tests are also used to monitor the progress of a patient's cancer treatment.
The Cancer Profiling market is highly competitive, with many companies offering a variety of tests. Some of the major players in the market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and Roche. Show Less Read more